latest news releases from the newsroom
Aceto Corporation Declares Semi-Annual Cash Dividend
LAKE SUCCESS, N.Y., Dec. 5, 2008 (GLOBE NEWSWIRE) -- Aceto Corporation (Nasdaq:ACET), a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and crop protection products, today announced that its Board of Directors has declared a regular semi-annual cash dividend of $0.10 per common share.
A Double Treat of Poetry -- New Book is a Bilingual Anthology in English and French
MONTREAL, Dec. 5, 2008 (GLOBE NEWSWIRE) -- Poetry is a wonderful medium where we can convey our creative thoughts and imaginative turns of phrases. It may be limited however by our choice of language. But when an author is bilingual, then that opens up the possibility of having twice the enjoyment. Journey with Dominique Garrel's Night Passage: Poems In Our Two Languages -- and see, in a double treat in English and French -- what the world and life at large have to offer.
Primoris Services Corporation
Primoris Services Corporation to Present At KeyBanc Capital Markets Engineering & Construction Conference
LAKE FOREST, Calif., Dec. 5, 2008 (GLOBE NEWSWIRE) -- Primoris Services Corporation (Nasdaq:PRIM) (Nasdaq:PRIMU) (Nasdaq:PRIMW) ("Primoris"), one of the largest specialty contractors and engineering companies in the United States, today announced that it is scheduled to present at the 2008 Engineering & Construction Conference sponsored by KeyBanc Capital Markets. This event will be held on Thursday, December 11, 2008 at The Grand Hyatt Hotel in New York City. The presentation will not be webcast, however, the presentation slides will be filed on Form 8-K with the SEC and will be available beginning December 11, 2008.
Northstar Neuroscience, Inc.
Northstar Neuroscience, Inc. Announces Chief Financial Officer Transition
SEATTLE, Dec. 5, 2008 (GLOBE NEWSWIRE) -- Northstar Neuroscience, Inc., (Nasdaq:NSTR), a medical device company developing therapies for the treatment of major depressive disorder, announced today that Raymond N. Calvert has resigned as Chief Financial Officer and Vice President, Finance to pursue other interests, effective December 31, 2008.
Momenta Pharmaceuticals Announces Appointment of James R. Sulat as Chairman of the Board of Directors
CAMBRIDGE, Mass., Dec. 5, 2008 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that James R. Sulat, a member of the Board of Directors since June 2008, has been named Chairman of the Board. He succeeds Peter Barrett, who is leaving the Board after 5 years of service, including serving as Chairman since June 2005.